Chris B Jones

Chris B Jones has extensive experience in the life sciences sector, currently serving as a Non-Executive Director at Rosa Biotech since July 2019. As a member of the University of Bath Ventures Board and the Commercialisation Executive Board from January 2013 to July 2023, Chris B Jones played a key role in overseeing investment strategies related to the university's technologies and intellectual property. Chris B Jones also held an honorary professorship in the Department of Pharmacy & Pharmacology. Chris B Jones founded and directed CBJ Life Sciences from July 2016 to August 2022, specializing in consultancy and investments in innovative pharmaceuticals. Previous roles include Non-Executive Director at Halo Therapeutics and Director at Alderley Park Ventures. Chris B Jones has a significant history with AstraZeneca, where tenure included positions such as Vice President and Global Head of Pharmaceutical Development. Academic achievements consist of a DSc (honoris causa) and a PhD in Pharmaceutical Sciences from the University of Bath, along with a Bachelor of Pharmacy degree.